Ingenza
Penicuik, United Kingdom ingenza.com
From their website, Nov 2026
Work here? Claim this listing
About
Ingenza is a technology-driven CRDMO established in 2003 and based in Edinburgh, UK. It works with clients developing complex biologics, small molecule pharmaceuticals, and sustainably manufactured industrial products, supporting development through manufacturing.
Services
codABLE™
AI/ML-based DNA optimisation for gene design and protein production.
Strain / Cell Line Development
Designs and develops mammalian, yeast, and bacterial hosts for biologics production, including cell line and microbial strain engineering.
Cell line development
Process Development
Develops upstream and downstream biologics processes, including fermentation, purification, and scale-up.
Analytical Development
Develops and qualifies analytical methods, assays, and in-process controls for biologics and small molecules.
Material Manufacturing
Manufactures pre-clinical biologics and small molecule material from milligram scale through larger batches, with non-GMP and GMP capability described.
CDMO: development & manufacturing
Bio-chemical Route Design
Designs chemical and biological routes for small molecule and biocatalytic synthesis.
Process Demonstration
Demonstrates biocatalytic, chemo-enzymatic, and fermentation-based routes to candidate molecules and drug substance material.
Sustainable Biotech
Supports sustainable bioprocessing and biomanufacturing for industrial applications.
Host Organisms
Develops host systems for sustainable biotech applications.
Chemicals
Supports biotech applications involving chemicals.
Enzymes & Personal Care
Supports enzyme and personal care applications using biotechnology.
Custom Solutions
Provides proof-of-concept, host development, process development, analytical development, and process demonstration/manufacturing for specialised biotech applications.
Proof-of-Concept and Feasibility Studies
Generates data points, pathway demonstrations, and material samples to support funding or technology validation.
Host Development
Tailors microbial and mammalian cell line-based hosts for target biomolecule production.
Cell line development
Capabilities
- Assays and studies
- Small molecules · Analytical development · Process development · Assay development · Product characterisation · Release assays · In-process controls · IPC/IPM · HTS assays · ELISA · Western blot · SDS-PAGE
3 more
HPLC · LC-MS · Analytical methods - Scale and capacity
- 250 mL high-throughput parallel bioreactors · 20 L scale glass or single-use culture vessels · Up to 20-L scale production and process demonstration · Up to kilogram quantities · Milligram to kilo scale · Small scale production runs (mg scale) up to multi-gram batches · Freeze drying up to 10 L · State-of-the-art facilities in Edinburgh
- Therapeutic areas
- Pharma · Biopharmaceutical production · Animal health · Food biotechnology · Materials · Agrobiotech
Instruments and platforms
- HPLC
- GCMS
- HRMS-QTOF
- LCMS
- AKTA
- Cedex Bio®
- LC-MS/MS
- Dynamic light scattering (DLS)
Modalities and species
- Modalities
- Small molecule · Peptide · Recombinant protein · Vaccine
- Species and models
- CHO cells · Mammalian cells · Yeast · Bacterial hosts · Microbial strains · Mammalian cell lines
Industries served
- Pharma
- Sustainable technology
- Agrobiotech
- Animal health
- Food biotechnology
- Materials
- Biotech
Company
- Type
- CRDMO
- Founded
- 2003
- Quality
- GLP (analytical methods) · Pharmacopeia standards (analytical methods) · ICH Q10 (QMS) · ICH Q7 (GMP requirements) · ICH guidelines (analytical methods) · GLP/GMP compliant environment
Locations
- Based in
- Penicuik, United Kingdom
- Sites
- Edinburgh, UK · Penicuik, UK
- Serves
- global
Contacts
- General enquiry
- info@ingenza.com on their site
- Phone
- +44 (0)1968 708620
Similar labs
Work here? Claim this listing